Cargando…

Tissue biodistribution and tumor targeting of near-infrared labelled anti-CD38 antibody-drug conjugate in preclinical multiple myeloma

Daratumumab (DARA) is an FDA-approved high-affinity monoclonal antibody targeting CD38 that has shown promising therapeutic efficacy in double refractory multiple myeloma (MM) patients. Despite the well-established clinical efficacy of DARA, not all heavily pretreated patients respond to single-agen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Nicholas, Ko, Sooah, Shokeen, Monica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487729/ https://www.ncbi.nlm.nih.gov/pubmed/34611478 http://dx.doi.org/10.18632/oncotarget.28074

Ejemplares similares

Anti CD38 monoclonal antibodies for multiple myeloma treatment
por: Gozzetti, Alessandro, et al.
Publicado: (2022)

Pharmacokinetic and Biodistribution Assessment of a Near Infrared-Labeled PSMA-Specific Small Molecule in Tumor-Bearing Mice
por: Kovar, Joy L., et al.
Publicado: (2014)

The Anti-CD38 Antibody Therapy in Multiple Myeloma
por: Petrucci, Maria Teresa, et al.
Publicado: (2019)

In Vivo Activation of Duocarmycin–Antibody Conjugates by Near-Infrared Light
por: Nani, Roger R., et al.
Publicado: (2017)

Preclinical Rationale for Targeting the PD-1/PD-L1 Axis in Combination with a CD38 Antibody in Multiple Myeloma and Other CD38-Positive Malignancies
por: Verkleij, Christie P. M., et al.
Publicado: (2020)

Controversy in the Use of CD38 Antibody for Treatment of Myeloma: Is High CD38 Expression Good or Bad?
por: Plesner, Torben, et al.
Publicado: (2020)

Biodistribution of gadolinium- and near infrared-labeled human umbilical cord mesenchymal stromal cell-derived exosomes in tumor bearing mice
por: Abello, Javier, et al.
Publicado: (2019)

Altered biodistribution of an antibody--enzyme conjugate modified with polyethylene glycol.
por: Eno-Amooquaye, E. A., et al.
Publicado: (1996)

Conjugation of Antibodies with Radiogold Nanoparticles, as an Effector Targeting Agents in Radiobioconjugate Cancer Therapy: Optimized Labeling and Biodistribution Results
por: Garg, Pankaj, et al.
Publicado: (2017)

Preclinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma
por: Drent, Esther, et al.
Publicado: (2015)

(212)Pb α-Radioimmunotherapy Targeting CD38 in Multiple Myeloma: A Preclinical Study
por: Quelven, Isabelle, et al.
Publicado: (2020)

CD38 Antibodies in Multiple Myeloma: Mechanisms of Action and Modes of Resistance
por: van de Donk, Niels W.C.J., et al.
Publicado: (2018)

Regulation of CD38 on Multiple Myeloma and NK Cells by Monoclonal Antibodies
por: Wu, Hao-Tian, et al.
Publicado: (2022)

Comparative biodistributions of indium-111-labelled macrocycle chimeric B72.3 antibody conjugates in tumour-bearing mice.
por: Turner, A., et al.
Publicado: (1994)

Antibody Drug Conjugates of Near-Infrared Photoimmunotherapy (NIR-PIT) in Breast Cancers
por: Cui, Yingshu, et al.
Publicado: (2023)

Imaging and Selective Elimination of Glioblastoma Stem Cells with Theranostic Near-Infrared-Labeled CD133-Specific Antibodies
por: Jing, Hua, et al.
Publicado: (2016)

Preclinical characterization of ISB 1342, a CD38 × CD3 T-cell engager for relapsed/refractory multiple myeloma
por: Pouleau, Blandine, et al.
Publicado: (2023)

Long-term in vivo biodistribution and toxicity study of functionalized near-infrared persistent luminescence nanoparticles
por: Sun, Xia, et al.
Publicado: (2018)

Resistance Mechanisms towards CD38−Directed Antibody Therapy in Multiple Myeloma
por: Franssen, Laurens E., et al.
Publicado: (2020)

Immunomodulatory properties of CD38 antibodies and their effect on anticancer efficacy in multiple myeloma
por: Bisht, Kamlesh, et al.
Publicado: (2023)

Assessment of near-infrared fluorophores to study the biodistribution and tumor targeting of an IL13 receptor α2 antibody by fluorescence molecular tomography
por: Gupta, Parul, et al.
Publicado: (2017)

Near-Infrared Fluorescence Imaging in Preclinical Models of Glioblastoma
por: Llaguno-Munive, Monserrat, et al.
Publicado: (2023)

The effect of circulating antigen and radiolabel stability on the biodistribution of an indium labelled antibody.
por: Davidson, B. R., et al.
Publicado: (1991)

Perspectives for the Development of CD38-Specific Heavy Chain Antibodies as Therapeutics for Multiple Myeloma
por: Bannas, Peter, et al.
Publicado: (2018)

Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma
por: Sanchez, Larysa, et al.
Publicado: (2016)

Comparison of CD38 antibodies in vitro and ex vivo mechanisms of action in multiple myeloma
por: Kinder, Michelle, et al.
Publicado: (2021)

Near-Infrared Fluorescence Molecular Imaging of Ductal Carcinoma In Situ with CD44v6-Specific Antibodies in Mice: A Preclinical Study
por: Vermeulen, Jeroen F., et al.
Publicado: (2012)

Pharmacokinetics of Single Domain Antibodies and Conjugated Nanoparticles Using a Hybrid near Infrared Method
por: Su, Shiran, et al.
Publicado: (2021)

Antibody-conjugated gold nanoparticles as nanotransducers for second near-infrared photo-stimulation of neurons in rats
por: Liu, Jiansheng, et al.
Publicado: (2022)

Biodistribution of essential oil-conjugated silver nanoparticles
por: Gherasim, Oana, et al.
Publicado: (2020)

Preclinical Evaluation of Invariant Natural Killer T Cells Modified with CD38 or BCMA Chimeric Antigen Receptors for Multiple Myeloma
por: Poels, Renée, et al.
Publicado: (2021)

Localization of near-infrared labeled antibodies to the central nervous system in experimental autoimmune encephalomyelitis
por: Lee, Sangmin, et al.
Publicado: (2019)

Preclinical anti-tumour activity of HexaBody-CD38, a next-generation CD38 antibody with superior complement-dependent cytotoxic activity
por: Hiemstra, Ida H., et al.
Publicado: (2023)

In vivo near-infrared imaging for the tracking of systemically delivered mesenchymal stem cells: tropism for brain tumors and biodistribution
por: Kim, Seong Muk, et al.
Publicado: (2015)

Optical Imaging of Disseminated Leukemia Models in Mice with Near-Infrared Probe Conjugated to a Monoclonal Antibody
por: Pesnel, Sabrina, et al.
Publicado: (2012)

CD38-Directed Therapies for Management of Multiple Myeloma
por: Hashmi, Hamza, et al.
Publicado: (2021)

Monoclonal Antibodies and Antibody Drug Conjugates in Multiple Myeloma
por: Radocha, Jakub, et al.
Publicado: (2021)

Open-[60]fullerene–aniline conjugates with near-infrared absorption
por: Sadai, Shumpei, et al.
Publicado: (2023)

Photoacoustic imaging with an acoustic lens detects prostate cancer cells labeled with PSMA-targeting near-infrared dye-conjugates
por: Dogra, Vikram, et al.
Publicado: (2016)

Near Infrared Photoimmunotherapy in the Treatment of Pleural Disseminated NSCLC: Preclinical Experience
por: Sato, Kazuhide, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_n8s8b424632k4o0b7o80qorl1t